Starbucks, Workers United Reportedly Agree to Withdraw Lawsuits-February 2024-www.financetom.com

Starbucks, Workers United Reportedly Agree to Withdraw Lawsuits

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Starbucks, Workers United Reportedly Agree to Withdraw Lawsuits

Feb 3, 2025 4:23 AM

07:01 AM EST, 02/03/2025 (MT Newswires) -- Starbucks ( SBUX ) and its union representing over 10,000 baristas, Workers United, have agreed to withdraw lawsuits against each other, multiple media outlets reported Friday citing the company.

This comes one day after the parties agreed to allow a mediator to help negotiations which started in April 2024, the reports said, adding that this decision brings them closer to reaching a contract.

Starbucks ( SBUX ) and Workers United did not immediately respond to MT Newswires' request for comment.

Previous page： Lithium Americas Finalizes Amendments to $2.23 Billion DOE Loan for Thacker Pass Project; Shares Up Pre-Bell Next page： Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Lithium Americas Finalizes Amendments to $2.23 Billion DOE Loan for Thacker Pass Project; Shares Up Pre-Bell

Oct 8, 2025

05:59 AM EDT, 10/08/2025 (MT Newswires) -- Lithium Americas ( LAC ) said late Tuesday it finalized certain amendments to the company's $2.23 billion loan from the US Department of Energy for financing the construction of processing facilities at the Thacker Pass joint venture project with General Motors ( GM ) . The DOE has agreed to defer $184 million...

Zenas Bio inks potential $2 billion licensing deal with China's InnoCare for autoimmune drug

Oct 8, 2025

Oct 8 (Reuters) - Zenas BioPharma ( ZBIO ) said on Wednesday it has secured global rights to develop and commercialize an experimental drug from China-based InnoCare Pharma for multiple sclerosis and other autoimmune conditions under a licensing deal potentially worth more than $2 billion. The deal grants Zenas worldwide rights to the drug, orelabrutinib, outside oncology. The U.S.-based drug...

Anglo CEO still sees future in Africa despite shrinking footprint

Oct 8, 2025

Oct 8 (Reuters) - Anglo American still considers Africa to be part of its future due to its critical mineral resources, despite the mining company's recent restructuring and disposal of assets there, CEO Duncan Wanblad said on Wednesday. Anglo American has exited its coal and platinum operations in South Africa, the country where it was founded over a century ago,...

Walker & Dunlop Arranges $356 Million for Boston Area Portfolio

Oct 8, 2025

BETHESDA, Md.--(BUSINESS WIRE)-- Walker & Dunlop, Inc. ( WD ) announced today that it arranged $356,411,000 in financing for the acquisition of four properties, all located within prominent New England MSAs. Walker & Dunlop Capital Markets, led by Craig West and team, arranged the portfolio financing on behalf of an affiliate longtime client, Harbor Group International, with Freddie Mac providing...